ATE388710T1 - Phthalazinderivate als phosphodiesterase-4-hemmer - Google Patents

Phthalazinderivate als phosphodiesterase-4-hemmer

Info

Publication number
ATE388710T1
ATE388710T1 AT03795950T AT03795950T ATE388710T1 AT E388710 T1 ATE388710 T1 AT E388710T1 AT 03795950 T AT03795950 T AT 03795950T AT 03795950 T AT03795950 T AT 03795950T AT E388710 T1 ATE388710 T1 AT E388710T1
Authority
AT
Austria
Prior art keywords
inhibitors
phosphodiesterase
phthalazine derivatives
phthalazine
derivatives
Prior art date
Application number
AT03795950T
Other languages
English (en)
Inventor
Mauro Napoletano
Franco Pellacini
Gabriele Morazzoni
Jean-Dominique Moriggi
Carlo Riva
Thomas Haack
Leopoldo Allievi
Marco Pauselli
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Application granted granted Critical
Publication of ATE388710T1 publication Critical patent/ATE388710T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT03795950T 2002-12-23 2003-12-22 Phthalazinderivate als phosphodiesterase-4-hemmer ATE388710T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002739A ITMI20022739A1 (it) 2002-12-23 2002-12-23 Derivati ftalazinici inibitori della fosfodiesterasi 4.

Publications (1)

Publication Number Publication Date
ATE388710T1 true ATE388710T1 (de) 2008-03-15

Family

ID=32676857

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03795950T ATE388710T1 (de) 2002-12-23 2003-12-22 Phthalazinderivate als phosphodiesterase-4-hemmer

Country Status (12)

Country Link
US (1) US20060166996A1 (de)
EP (1) EP1581229B1 (de)
JP (1) JP2006516127A (de)
CN (1) CN100366618C (de)
AT (1) ATE388710T1 (de)
AU (1) AU2003298228A1 (de)
CA (1) CA2511182A1 (de)
DE (1) DE60319743D1 (de)
IL (1) IL169334A0 (de)
IT (1) ITMI20022739A1 (de)
RU (1) RU2329262C2 (de)
WO (1) WO2004056366A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2657093A1 (en) * 2006-07-07 2008-01-10 Steven P. Govek Bicyclic heteroaryl inhibitors of pde4

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19756790A1 (de) * 1997-12-19 1999-07-01 Fraunhofer Ges Forschung Prepolymer mit darin isoliert dispergierten nanoskaligen Feststoffteilchen, Verfahren zu seiner Herstellung und seine Verwendung
IT1296984B1 (it) * 1997-12-19 1999-08-03 Zambon Spa Derivati ftalazinici inibitori della fosfodiesterasi 4
ITMI981670A1 (it) * 1998-07-21 2000-01-21 Zambon Spa Derivati ftalazinici inibitori della fosfodiesterasi 4
EP1098010A4 (de) * 1999-03-04 2003-08-06 Nippon Kokan Kk Stahlplatte für wärmeschrumpffähiges band und verfahren zu dessen herstellung
CN1660840A (zh) * 1999-03-30 2005-08-31 诺瓦提斯公司 治疗炎性疾病的酞嗪衍生物

Also Published As

Publication number Publication date
ITMI20022739A1 (it) 2004-06-24
CN100366618C (zh) 2008-02-06
AU2003298228A1 (en) 2004-07-14
CN1753679A (zh) 2006-03-29
RU2005119624A (ru) 2006-01-20
IL169334A0 (en) 2007-07-04
RU2329262C2 (ru) 2008-07-20
EP1581229B1 (de) 2008-03-12
WO2004056366A1 (en) 2004-07-08
JP2006516127A (ja) 2006-06-22
DE60319743D1 (de) 2008-04-24
US20060166996A1 (en) 2006-07-27
CA2511182A1 (en) 2004-07-08
EP1581229A1 (de) 2005-10-05

Similar Documents

Publication Publication Date Title
DE60313472D1 (de) Pyrrolidindion-substituierte piperidin-phthalazone als pde4-inhibitoren
DK1070056T3 (da) Phthalazinon-PDE III/IV-inhibitorer
ATE348616T1 (de) 2-hydroxy-6-phenylphenanthridine als pde-4-hemmer
ATE353217T1 (de) 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren
ATE449099T1 (de) Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren
NO20044995L (no) Heterosykliske forbindelser
DE602004024988D1 (de) 2-aminopyrimidin-derivate als raf-kinase-hemmer
ATE442847T1 (de) Benzimidazol-derivate als mek-hemmer
DE60112306D1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
ATE355265T1 (de) Biphenylcarboxamidderivate und ihre verwendung als p38 kinase inhibitoren
DE60316984D1 (de) Benzoylsulfonamide als antitumor-mittel
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
ATE259813T1 (de) Triazolopyrimidinderivate
DE60127131D1 (de) Tricyclische imidazopyridine
DE60036558D1 (de) Phthalazinon-derivate als pde 4 hemmer
ATE337320T1 (de) Indolderivate als pde5-inhibitoren
ATE287403T1 (de) 6-phenylbenzonaphthyidine
DE60110124D1 (de) Kondensierte pyrazindionderivate als pde inhibitoren
ATE403655T1 (de) Imidazopyridinderivate als induzierbare no- synthaseinhibitoren
ATE360422T1 (de) Tetrazyklische verbindungen als pde5-inhibitoren
ATE388710T1 (de) Phthalazinderivate als phosphodiesterase-4-hemmer
ATE508130T1 (de) 3-oxa-10-aza-phenanthrene als pde4- oder pde3/4- inhibitoren
DE602004019939D1 (de) Thiazolderivate als npy-antagonisten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties